Prolactin-induced expression of vascular endothelial growth factor via Egr-1

被引:66
作者
Goldhar, AS
Vonderhaar, BK
Trott, JF
Hovey, RC
机构
[1] Univ Vermont, Dept Anim Sci, Lactat & Mammary Gland Biol Grp, Burlington, VT 05405 USA
[2] NCI, Mammary Biol & Tumorigenesis Lab, NIH, Bethesda, MD 20892 USA
关键词
angiogenesis; prolactin; mammary gland; lymphoma;
D O I
10.1016/j.mce.2005.01.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Angiogenesis is a dynamic process regulated by both local and systemic factors. Among these is vascular endothelial growth factor (VEGF), a potent effector of angiogenesis and vascular permeability. Previously we showed that VEGF is temporally and spatially regulated in the mouse mammary gland during development and lactation. Given the functions of prolactin (PRL) during these stages and the supporting role of the vasculature, we investigated the regulation of VEGF by PRL. Treatment of HC11 mouse mammary epithelial and Nb2 rat lymphoma cells with PRL induced VEGF expression. Deletion and mutation analysis identified a GC-rich region in the proximal region of the VEGF promoter that constitutively bound Sp1 and PRL-induced Egr-1. These sites conferred PRL-responsiveness leading to increased VEGF transcription. The induction of VEGF by PRL was PRL receptor-, Jak2- and MAP kinase kinase-dependent. Our results indicate that PRL induces VEGF expression through Egr-1, and implicates VEGF as an intermediary of PRL-regulated angiogenesis. Published by Elsevier Ireland Ltd.
引用
收藏
页码:9 / 19
页数:11
相关论文
共 70 条
[1]   Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblasts [J].
Aicher, WK ;
Alexander, D ;
Haas, C ;
Kuchen, S ;
Pagenstecher, A ;
Gay, S ;
Peter, HH ;
Eibel, H .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :348-359
[2]   PROLACTIN REGULATION OF BETA-CASEIN GENE-EXPRESSION AND OF A CYTOSOLIC 120-KD PROTEIN IN A CLONED MOUSE MAMMARY EPITHELIAL-CELL LINE [J].
BALL, RK ;
FRIIS, RR ;
SCHOENENBERGER, CA ;
DOPPLER, W ;
GRONER, B .
EMBO JOURNAL, 1988, 7 (07) :2089-2095
[3]  
Banerjee SK, 2000, INT J ONCOL, V16, P253
[4]  
Bole-Feysot C., 2000, GENOME BIOL, V1, P1
[5]   EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS FLT AND KDR IN OVARIAN-CARCINOMA [J].
BOOCOCK, CA ;
CHARNOCKJONES, DS ;
SHARKEY, AM ;
MCLAREN, J ;
BARKER, PJ ;
WRIGHT, KA ;
TWENTYMAN, PR ;
SMITH, SK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (07) :506-516
[6]   GENOMIC SEQUENCING [J].
CHURCH, GM ;
GILBERT, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07) :1991-1995
[7]   Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis [J].
Claffey, KP ;
Abrams, K ;
Shih, SC ;
Brown, LF ;
Mullen, A ;
Keough, M .
LABORATORY INVESTIGATION, 2001, 81 (01) :61-75
[8]   ANALYSIS OF THE PROTEOLYTIC CLEAVAGE OF PROLACTIN BY THE MAMMARY-GLAND AND LIVER OF THE RAT - CHARACTERIZATION OF THE CLEAVED AND 16K FORMS [J].
CLAPP, C .
ENDOCRINOLOGY, 1987, 121 (06) :2055-2064
[9]   THE 16-KILODALTON N-TERMINAL FRAGMENT OF HUMAN PROLACTIN IS A POTENT INHIBITOR OF ANGIOGENESIS [J].
CLAPP, C ;
MARTIAL, JA ;
GUZMAN, RC ;
RENTIERDELRUE, F ;
WEINER, RI .
ENDOCRINOLOGY, 1993, 133 (03) :1292-1299
[10]   Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis [J].
Corbacho, AM ;
de las Escalera, GM ;
Clapp, C .
JOURNAL OF ENDOCRINOLOGY, 2002, 173 (02) :219-238